High Tower Advisors, LLC Oramed Pharmaceuticals Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.12 - $4.47 $22,260 - $46,935	10,500 New	10,500 $37,000
Q4 2022 Feb 08, 2023	BUY	$5.88 - $12.03 $2,916 - $5,966	496 Added 1.55%	32,500 $390,000
Q3 2022 Nov 09, 2022	BUY	$4.6 - $9.91 $69,018 - $148,689	15,004 Added 88.26%	32,004 $206,000
Q2 2022 Aug 10, 2022	BUY	$3.72 - $9.0 $11,160 - $27,000	3,000 Added 21.43%	17,000 $79,000
Q4 2021 Feb 10, 2022	SELL	$12.98 - $29.75 $181,720 - $416,500	-14,000 Reduced 50.0%	14,000 $199,000
Q3 2021 Nov 12, 2021	SELL	$12.13 - $23.82 $12,130 - $23,820	-1,000 Reduced 3.45%	28,000 $616,000
Q2 2021 Aug 06, 2021	BUY	$8.34 - $14.59 $41,700 - $72,950	5,000 Added 20.83%	29,000 $389,000
Q1 2021 May 10, 2021	BUY	$4.22 - $11.33 $44,310 - $118,965	10,500 Added 77.78%	24,000 $243,000
Q4 2020 Feb 10, 2021	BUY	$2.48 - $4.64 $33,480 - $62,639	13,500 New	13,500 $57,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.